Cargando…
PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis
Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus’s dynamicity has resulted in the evolution of various variants, including the delta variant and the more novel mu variant. With a multitude of mutant strains posing as challenges to vaccin...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698348/ https://www.ncbi.nlm.nih.gov/pubmed/34944683 http://dx.doi.org/10.3390/biomedicines9121867 |